Creon 6000 [USP'U]/1

Creon 6000 is a prescription medication containing pancrelipase, an enzyme replacement therapy. It is used to treat people who cannot digest food normally because their pancreas does not make enough enzymes. The medication works by replacing the enzymes that the pancreas is not producing, allowing for proper digestion and absorption of nutrients. Creon 6000 is available in a delayed-release capsule form.

Creon 6000 is used to treat exocrine pancreatic insufficiency (EPI), a condition where the pancreas does not produce enough digestive enzymes. This condition can occur in people with cystic fibrosis, chronic pancreatitis, or those who have had their pancreas removed or are at risk of pancreatitis. The medication helps to replace the missing enzymes, allowing for proper digestion and absorption of nutrients from food.

Common side effects of Creon 6000 include abdominal pain, diarrhea, and cough. Less common but more serious side effects can include allergic reactions, such as hives, itching, or difficulty breathing. Patients should be monitored for any signs of allergic reactions or other adverse effects and report them to their healthcare provider.

Creon 6000 should be stored at room temperature, away from moisture and heat. The capsules should not be crushed or chewed, as this can cause the enzymes to be released too quickly, reducing their effectiveness. Patients should follow the dosage instructions provided by their healthcare provider and take the medication with meals to help ensure proper digestion and minimize side effects.

Creon 6000 may interact with other medications, such as antacids or acid-reducing medications, which can affect the absorption of the enzymes. Patients should inform their healthcare provider of all medications they are taking before starting Creon 6000. Additionally, patients with certain medical conditions, such as gout or kidney disease, may require dose adjustments or closer monitoring while taking Creon 6000.